ROCK-II inhibition suppresses impaired mechanobiological responses in early estrogen deficient osteoblasts

Exp Cell Res. 2020 Nov 1;396(1):112264. doi: 10.1016/j.yexcr.2020.112264. Epub 2020 Sep 6.

Abstract

Mechanobiological responses by osteoblasts are governed by downstream Rho-ROCK signalling through actin cytoskeleton re-arrangements but whether these responses are influenced by estrogen deficiency during osteoporosis remains unknown. The objective of this study was to determine alterations in the mechanobiological responses of estrogen-deficient osteoblasts and investigate whether an inhibitor of the Rho-ROCK signalling can revert these changes. MC3T3-E1 cells were pre-treated with 10 nM 17-β estradiol for 7 days and further cultured with or without estradiol for next 2 days. These cells were treated with or without ROCK-II inhibitor, Y-27632, and oscillatory fluid flow (OFF, 1Pa, 0.5 Hz, 1 h) was applied. Here, we report that Prostaglandin E2 release, Runt-related transcription factor 2 and Osteopontin gene expression were significantly enhanced in response to OFF in estrogen-deficient cells than in cells with estrogen (3.73 vs 1.63 pg/ng DNA; 13.5 vs 2.6 fold, 2.1 vs 0.4 fold respectively). Upon ROCK-II inhibition, these enhanced effects of estrogen deficiency were downregulated. OFF increased the fibril anisotropy in cells pre-treated with estrogen and this increase was suppressed upon ROCK-II inhibition. This study is the first to demonstrate altered mechanobiological responses by osteoblasts during early estrogen deficiency and that these responses to OFF can be suppressed upon ROCK inhibition.

Keywords: Estrogen; Mechanobiology; Osteoporosis; Rho-associated coiled kinase (ROCK).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / metabolism
  • Actin Cytoskeleton / ultrastructure
  • Alkaline Phosphatase / genetics
  • Alkaline Phosphatase / metabolism
  • Amides / pharmacology
  • Animals
  • Cell Differentiation / drug effects
  • Cell Line
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / metabolism
  • Estradiol / pharmacology*
  • Gene Expression Regulation
  • Mechanotransduction, Cellular / genetics*
  • Mice
  • Osteoblasts / cytology
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism
  • Osteogenesis / drug effects*
  • Osteogenesis / genetics
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • Pyridines / pharmacology
  • Rheology
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / genetics*
  • rho-Associated Kinases / metabolism

Substances

  • Amides
  • Core Binding Factor Alpha 1 Subunit
  • Protein Kinase Inhibitors
  • Pyridines
  • Runx2 protein, mouse
  • Spp1 protein, mouse
  • Osteopontin
  • Y 27632
  • Estradiol
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Rock2 protein, mouse
  • rho-Associated Kinases
  • Alkaline Phosphatase
  • Dinoprostone